Correlation Between Dyadic International and XORTX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyadic International and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and XORTX Therapeutics, you can compare the effects of market volatilities on Dyadic International and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and XORTX Therapeutics.

Diversification Opportunities for Dyadic International and XORTX Therapeutics

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dyadic and XORTX is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and XORTX Therapeutics go up and down completely randomly.

Pair Corralation between Dyadic International and XORTX Therapeutics

Given the investment horizon of 90 days Dyadic International is expected to under-perform the XORTX Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dyadic International is 1.56 times less risky than XORTX Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The XORTX Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  131.00  in XORTX Therapeutics on December 5, 2024 and sell it today you would lose (26.00) from holding XORTX Therapeutics or give up 19.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dyadic International  vs.  XORTX Therapeutics

 Performance 
       Timeline  
Dyadic International 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dyadic International are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Dyadic International may actually be approaching a critical reversion point that can send shares even higher in April 2025.
XORTX Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, XORTX Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Dyadic International and XORTX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyadic International and XORTX Therapeutics

The main advantage of trading using opposite Dyadic International and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.
The idea behind Dyadic International and XORTX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance